Ampreloxetine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ampreloxetine, covering 2025-09-05 to 2025-09-05. Get the full timeline:
Most recent: Clinical Trial Update: Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy [Phase 3]